Fair Value Measurements and Hierarchy - Carrying Value of Financial Instruments (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 11 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 02, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||||||
| Cash | $ 100,935 | $ 179,512 | ||||||||
| P3 Health Partners Inc. | ||||||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||||||
| Financial Designation, Predecessor and Successor [Fixed List] | Successor | Successor | Successor | Predecessor | Predecessor | Successor | Predecessor | Predecessor | Predecessor | Predecessor |
| Cash | $ 140,477,586 | $ 140,477,586 | $ 63,145,379 | $ 16,322,893 | $ 63,145,379 | $ 16,322,893 | $ 5,300,842 | $ 36,261,104 | $ 32,592,496 | |
| Restricted Cash | 356,286 | 356,286 | 753,920 | $ 223,872 | 753,920 | $ 223,872 | $ 54,095 | 3,641,843 | $ 312,352 | |
| Clinic Fees and Insurance Receivables, Net | 1,090,104 | 1,090,104 | 1,931,291 | 1,931,291 | 675,954 | |||||
| Other Receivables | 726,903 | 726,903 | 261,935 | 261,935 | 146,117 | |||||
| Accounts Payable and Accrued Expenses | 17,730,683 | 17,730,683 | 20,693,070 | 20,693,070 | 11,793,125 | |||||
| Liability for warrants | $ 11,382,826 | $ 11,382,826 | $ 5,429,009 | $ 5,429,009 | $ 6,316,605 | |||||
| X | ||||||||||
- Definition The carrying amount of clinic fees and insurance receivables, net due within one year or the normal operating cycle, if longer. No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Indicates designation of financial information when substantially all business or separately identifiable line of business transfers from one entity to another entity. Acceptable values are "Predecessor" and "Successor". Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer. No definition available.
|
| X | ||||||||||
- Definition Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|